Article Text

Download PDFPDF
Brief encounters
  1. Helen Ward,
  2. Rob Miller, Editors

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    In the USA, cefoxitin and doxycycline is one of the standard pelvic inflammatory disease (PID) treatment regimens. In an observational study of 682 women with PID, Haggerty and colleagues looked at short and long term outcomes in women treated with these two drugs. Outcomes were worse in women who had Mycoplasma genitalium at baseline. Women with M genitalium were three times more likely to have endometritis at baseline, and were almost five times more likely to have a short term treatment failure: 44% failed to clear the organism at 30 days. There was also a non-significant trend to worse longer term outcomes for …

    View Full Text

    Linked Articles